Indaptus Therapeutics, Inc.INDPNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank87
3Y CAGR+64.8%
5Y CAGR-2.0%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+64.8%/yr
vs +15.2%/yr prior
5Y CAGR
-2.0%/yr
Recent acceleration
Acceleration
+49.6pp
Accelerating
Percentile
P87
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 43.10% |
| Q2 2025 | -15.37% |
| Q1 2025 | -9.72% |
| Q4 2024 | -34.60% |
| Q3 2024 | 23.57% |
| Q2 2024 | -5.48% |
| Q1 2024 | 4.90% |
| Q4 2023 | -2.05% |
| Q3 2023 | -20.87% |
| Q2 2023 | 23.70% |
| Q1 2023 | -16.34% |
| Q4 2022 | -5.46% |
| Q3 2022 | 9.62% |
| Q2 2022 | -13.98% |
| Q1 2022 | -4.63% |
| Q4 2021 | 4.48% |
| Q3 2021 | -553.21% |
| Q2 2021 | 15.83% |
| Q1 2021 | 20.49% |
| Q4 2020 | 50.07% |
| Q3 2020 | 47.65% |
| Q2 2020 | -427.59% |
| Q1 2020 | 91.48% |
| Q4 2019 | 67.83% |
| Q3 2019 | -103.60% |
| Q2 2019 | 6.07% |
| Q1 2019 | 15.45% |
| Q4 2018 | -37.32% |
| Q3 2018 | 16.81% |
| Q2 2018 | -2.83% |
| Q1 2018 | -4.82% |
| Q4 2017 | -33.77% |
| Q3 2017 | -17.34% |
| Q2 2017 | -44.91% |
| Q1 2017 | 0.00% |
| Q4 2015 | -113.39% |
| Q3 2015 | -58.36% |
| Q2 2015 | 53.84% |
| Q1 2015 | 0.00% |